Eco R1 Capital, LLC Portfolio Holdings

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Eco R1 Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.31 Billion distributed in 64 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $343M, Crinetics Pharmaceuticals, Inc. with a value of $219M, Prothena Corp Public LTD CO with a value of $194M, Jazz Pharmaceuticals PLC with a value of $190M, and Arvinas, Inc. with a value of $166M.

Examining the 13F form we can see an decrease of $524M in the current position value, from $2.83B to 2.31B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.31 Billion
Healthcare: $2.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.02B
$343 Million 14.88% of portfolio
11,890,843
Q3 2024 Added 2.44%
$3.01B
$219 Million 9.5% of portfolio
4,288,120
Q3 2024 Added 3.19%
$676M
$194 Million 8.41% of portfolio
11,584,280
Q1 2022 Added 2.66%
$7.47B
$190 Million 8.25% of portfolio
1,706,469
Q3 2024 Added 68.3%
$1.21B
$166 Million 7.19% of portfolio
6,726,491
Q4 2023 Added 23.04%
$1.06B
$113 Million 4.92% of portfolio
5,806,871
Q2 2023 Reduced 12.53%
$1.42B
$107 Million 4.65% of portfolio
5,330,416
Q1 2024 Added 0.91%
$359M
$103 Million 4.45% of portfolio
13,330,736
Q4 2023 Added 52.85%
$2.04B
$66.8 Million 2.9% of portfolio
1,469,818
Q2 2024 New
$3.69B
$65.3 Million 2.83% of portfolio
1,389,276
Q1 2024 New
$115M
$56.7 Million 2.46% of portfolio
3,879,415
Q4 2023 New
$1.58B
$51.5 Million 2.24% of portfolio
3,223,851
Q3 2024 Reduced 43.58%
$807M
$44.6 Million 1.93% of portfolio
1,958,847
Q3 2024 New
$560M
$44.2 Million 1.92% of portfolio
19,209,643
Q3 2023 Added 38.23%
$469M
$43.1 Million 1.87% of portfolio
3,182,444
Q4 2023 Added 6.71%
$5.1B
$40.2 Million 1.75% of portfolio
352,464
Q3 2024 Added 17.49%
$352M
$35 Million 1.52% of portfolio
3,418,068
Q1 2022 Reduced 1.47%
$2.28B
$34.8 Million 1.51% of portfolio
757,576
Q1 2024 New
$2.02B
$33.4 Million 1.45% of portfolio
1,250,385
Q1 2024 Reduced 64.21%
$109M
$26 Million 1.13% of portfolio
27,404,070
Q1 2024 New
$79.3M
$24.9 Million 1.08% of portfolio
5,000,000
Q2 2023 New
$204M
$22.9 Million 0.99% of portfolio
3,917,546
Q1 2024 Added 1.71%
$1.23B
$22.1 Million 0.96% of portfolio
650,000
Q1 2024 New
$604M
$20.6 Million 0.9% of portfolio
910,000
Q2 2024 New
$1.55B
$20 Million 0.87% of portfolio
555,644
Q3 2024 Added 30.12%
$5.02B
$20 Million 0.87% of portfolio
500,000
Q3 2024 New
$263M
$18.2 Million 0.79% of portfolio
5,441,896
Q2 2024 Reduced 11.45%
$560M
$17.7 Million 0.77% of portfolio
2,500,000
Q3 2024 New
$692M
$16.7 Million 0.72% of portfolio
900,000
Q4 2023 New
$279M
$16.4 Million 0.71% of portfolio
1,608,616
Q3 2024 Reduced 50.5%
$5.42B
$15.9 Million 0.69% of portfolio
75,000
Q1 2024 New
$1B
$12 Million 0.52% of portfolio
862,068
Q3 2024 New
$1.39B
$10.9 Million 0.47% of portfolio
187,500
Q1 2024 New
$52.1M
$9.15 Million 0.4% of portfolio
11,294,585
Q1 2024 New
$554M
$9.32 Million 0.4% of portfolio
850,341
Q2 2024 New
$273M
$6.05 Million 0.26% of portfolio
1,250,000
Q4 2023 New
$79.7M
$5.06 Million 0.22% of portfolio
2,046,867
Q2 2023 Added 4.61%
$1.69B
$4.46 Million 0.19% of portfolio
155,006
Q3 2024 Reduced 97.31%
$3.42B
$4.33 Million 0.19% of portfolio
170,172
Q3 2024 New
$46.4M
$3.8 Million 0.16% of portfolio
1,845,253
Q3 2024 New
$258M
$3.4 Million 0.15% of portfolio
566,075
Q3 2024 New
$259M
$3.34 Million 0.14% of portfolio
1,835,991
Q3 2024 Reduced 10.12%
$286M
$2.71 Million 0.12% of portfolio
700,000
Q1 2024 New
$306M
$289,000 0.01% of portfolio
53,834
Q3 2024 New
$85.6M
$125,000 0.01% of portfolio
192,346
Q3 2024 New
$214M
$184,000 0.01% of portfolio
56,018
Q3 2024 New
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$0
$1,000 0.0% of portfolio
100,000
Q2 2021 New

Summary

  • Portfolio
  • No. of Stocks 64
  • Current Value $2.31 Billion
  • Prior Value $2.83 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 14 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email